An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma

Front Immunol. 2018 Mar 12:9:511. doi: 10.3389/fimmu.2018.00511. eCollection 2018.

Abstract

Native C-reactive protein (nCRP) is a non-specific marker of inflammation being claimed as a bystander in several chronic disorders. Accumulating evidence indicates that nCRP dissociates to and acts primarily as the monomeric conformation (mCRP) at inflammatory loci. This suggests that mCRP may be a superior disease marker with improved specificity and clear causality to the underlying pathogenesis. However, the lack of a feasible assay to quantify mCRP in clinical samples precludes the assessment of that suggestion. Here we report the development of a sandwich ELISA assay for quantification of plasma mCRP using commercially available reagents. Our assay is reproducible and highly conformation-specific showing a reliable detection limit of 1 ng/mL. We further show that mCRP appears to be a better marker than nCRP in several skin-related autoimmune disorders. This assay thus provides a useful tool to examine the clinical significance and utility of mCRP.

Keywords: C-reactive protein; autoimmune diseases; inflammation; monomeric C-reactive protein; psoriasis; urticaria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies / immunology
  • C-Reactive Protein / analysis*
  • C-Reactive Protein / immunology
  • Eczema / blood
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Psoriasis / blood
  • Urticaria / blood

Substances

  • Antibodies
  • C-Reactive Protein